Regulations.gov document

Reclassifications of Category IIIA Biological Products, Bacterial Vaccines and Related…

Notice · FDA-2000-N-0163 · posted Dec 6, 2010

Key facts

Document ID FDA-2000-N-0163-0023
Title Reclassifications of Category IIIA Biological Products, Bacterial Vaccines and Related Biological Products, etc.: Delmont Laboratories, Inc.; Denial of Request for Hearing and Revocation of License
Document type Notice
Subtype NFR-Notice of Final Rule
Agency FDA
Docket FDA-2000-N-0163
Posted Dec 6, 2010
Federal Register citation 75 FR 75682
FR document number 2010-30441
Comment period opens Dec 6, 2010
Effective date Dec 6, 2010

At a glance

  • 1–9 Pages
  • 1–9 Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents